EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Tumor‐Infiltrating Nociceptor Neurons in Ovarian Cancer Treatment Resistance

Allison Jorgensen, Daniel W Vermeer, Euihye Jung, Caitlin S Williamson, Dalia K Omran, Lauren E Schwartz, Ju-Yoon Yoon, Jeffrey Barr, Ashley L Tetlow, Camille V Trinidad, Ronny Drapkin, Andrew K Godwin und 1 weitere

Advanced Biology · 2026-03 · 10 (3)

DOI: 10.1002/adbi.202500404 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Biology, online erschienen am 09.03.2026. Verfasst von Allison Jorgensen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Biology and Immunotherapies Group, Sanford Research, Sioux Falls, South Dakota, USA. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIGMS NIH HHS, National Institutes of Health P50, Predicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with densely innervated tumors suffer with poor outcomes, thus identifying them could define a cohort that could benefit from aggressive treatments. Most cases and deaths from ovarian cancer are associated with high‐grade serous ovarian carcinoma (HGSOC). We immunohistochemically analyzed the histological subtypes of ovarian cancer (high‐grade serous, low‐grade serous, clear cell, mucinous, and endometrioid) for nerves; only HGSOCs were densely innervated. We previously defined that tumor‐released small extracellular vesicles (sEVs) recruit nerves to the tumor bed and thus tested whether the difference in nerve infiltration amongst ovarian cancers was associated with sEVs. Using an in vitro neurite outgrowth assay, we found that HGSOC sEVs harbored robust neurite outgrowth activity. Importantly, sEVs from fallopian tube cell lines (the primary cell of origin of HGSOC) predominantly lacked this activity. Implantation of a syngeneic mouse model of HGSOC into transgenic mice lacking tumor‐infiltrating nerves slowed tumor growth, sensitized disease to carboplatin, and improved survival. Consistent with this, we show that recurrent, treatment‐resistant disease in patients is significantly more innervated than its matched naïve (untreated) malignancy. Taken together, these data identify dense nerve infiltration of HGSOCs and show that innervation contributes to treatment resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsDrug Resistance, NeoplasmFemaleAnimalsHumansMiceCell Line, TumorExtracellular VesiclesMice, Transgenic

Stichwörter der Autor:innen

neurite outgrowthnociceptor neuronsovarian cancersmall extracellular vesiclestumor‐infiltrating nerves

Autor:innen und Institutionen

  • Cancer Biology and Immunotherapies Group, Sanford Research, Sioux Falls, South Dakota, USA.
  • Penn Ovarian Cancer Research Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Department of Pathology and Laboratory Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.

ORCID-Profile: Paola D Vermeer

Förderung

  • NIGMS NIH HHS
  • National Institutes of Health P50
  • Predicine
  • NCI NIH HHS
  • Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
  • Ovarian Cancer Research Fund Alliance
  • NIH HHS
  • Honorable Tina Brozman Foundation

Zitieren

APA

Jorgensen, A., Vermeer, D. W., Jung, E., Williamson, C. S., Omran, D. K., Schwartz, L. E., Yoon, J. Y., Barr, J., Tetlow, A. L., Trinidad, C. V., Drapkin, R., Godwin, A. K., & Vermeer, P. D. (2026). Tumor‐Infiltrating Nociceptor Neurons in Ovarian Cancer Treatment Resistance. Advanced Biology, 10(3). https://doi.org/10.1002/adbi.202500404

Vancouver

Jorgensen A, Vermeer DW, Jung E, Williamson CS, Omran DK, Schwartz LE, et al. Tumor‐Infiltrating Nociceptor Neurons in Ovarian Cancer Treatment Resistance. Advanced Biology. 2026;10(3). doi:10.1002/adbi.202500404

BibTeX
@article{Jorgensen2026,
  author = {Jorgensen, Allison and Vermeer, Daniel W and Jung, Euihye and Williamson, Caitlin S and Omran, Dalia K and Schwartz, Lauren E and Yoon, Ju-Yoon and Barr, Jeffrey and Tetlow, Ashley L and Trinidad, Camille V and Drapkin, Ronny and Godwin, Andrew K and Vermeer, Paola D},
  title = {Tumor‐Infiltrating Nociceptor Neurons in Ovarian Cancer Treatment Resistance},
  journal = {Advanced Biology},
  year = {2026},
  volume = {10},
  number = {3},
  doi = {10.1002/adbi.202500404}
}
Kostenlos starten →